| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.59B | 38.54B | 37.09B | 34.98B | 35.22B | 34.26B |
| Gross Profit | 4.50B | 4.72B | 4.18B | 3.89B | 3.87B | 3.59B |
| EBITDA | 5.66B | 6.00B | 5.34B | 5.28B | 5.26B | 5.41B |
| Net Income | 1.32B | 1.51B | 1.26B | 1.15B | 1.23B | 1.09B |
Balance Sheet | ||||||
| Total Assets | 41.46B | 49.47B | 43.28B | 41.09B | 36.80B | 35.65B |
| Cash, Cash Equivalents and Short-Term Investments | 6.59B | 8.74B | 7.42B | 6.51B | 6.46B | 4.83B |
| Total Debt | 8.18B | 9.39B | 8.73B | 7.50B | 7.48B | 6.92B |
| Total Liabilities | 15.79B | 19.70B | 17.33B | 16.08B | 14.21B | 14.24B |
| Stockholders Equity | 25.67B | 29.77B | 25.95B | 25.01B | 22.59B | 21.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.58B | 3.62B | 2.44B | 3.62B | 2.38B |
| Operating Cash Flow | 0.00 | 5.76B | 5.11B | 4.98B | 4.71B | 4.67B |
| Investing Cash Flow | 0.00 | -2.37B | -2.61B | -3.13B | -1.05B | -2.25B |
| Financing Cash Flow | 0.00 | -2.80B | -2.60B | -1.82B | -2.05B | -1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥18.62B | 12.39 | ― | 1.96% | 3.90% | 19.67% | |
66 Neutral | ¥7.52B | 15.05 | ― | 0.89% | 16.59% | ― | |
64 Neutral | ¥7.56B | 6.63 | ― | 0.47% | 1.67% | 5.71% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥286.45B | 11.28 | ― | 1.61% | 1.51% | 14.84% | |
58 Neutral | ¥215.37B | 6.42 | 12.70% | 1.68% | 6.91% | 58.68% | |
58 Neutral | ¥41.05B | 11.36 | ― | 2.58% | 7.30% | -28.80% |